Ajit Ramalingam net worth and biography

Ajit Ramalingam Biography and Net Worth

Ajit Ramalingam serves as Senior Vice President, Chief Accounting Officer of the Company. Mr. Ramalingam has over twenty years of experience in accounting and financial management roles. Prior to joining the Company, Mr. Ramalingam, age 47, was the Vice President & Corporate Controller of Logitech, Inc., a manufacturer of computer peripherals and software, from October 2018 to March 2020. From 2016 through 2018, Mr. Ramalingam was the AVP Worldwide Controller of BroadSoft, Inc., a global communication software and service provider that was purchased by Cisco Systems in 2018, and from 2013 to 2016 he was the Senior Director, US Controller of BroadSoft. Prior to that, from 2005 to 2012, Mr. Ramalingam worked at PricewaterhouseCoopers, LLP as Senior Manager, Assurance.

What is Ajit Ramalingam's net worth?

The estimated net worth of Ajit Ramalingam is at least $40,967.92 as of August 5th, 2022. Mr. Ramalingam owns 98 shares of Bio-Rad Laboratories stock worth more than $40,968 as of December 2nd. This net worth evaluation does not reflect any other assets that Mr. Ramalingam may own. Learn More about Ajit Ramalingam's net worth.

How old is Ajit Ramalingam?

Mr. Ramalingam is currently 49 years old. There are 6 older executives and no younger executives at Bio-Rad Laboratories. The oldest executive at Bio-Rad Laboratories is Mr. Norman D. Schwartz, Chairman, CEO & Pres, who is 72 years old. Learn More on Ajit Ramalingam's age.

How do I contact Ajit Ramalingam?

The corporate mailing address for Mr. Ramalingam and other Bio-Rad Laboratories executives is 1000 ALFRED NOBEL DRIVE, HERCULES CA, 94547. Bio-Rad Laboratories can also be reached via phone at (510) 724-7000 and via email at [email protected] Learn More on Ajit Ramalingam's contact information.

Has Ajit Ramalingam been buying or selling shares of Bio-Rad Laboratories?

Ajit Ramalingam has not been actively trading shares of Bio-Rad Laboratories during the last ninety days. Most recently, Ajit Ramalingam sold 518 shares of the business's stock in a transaction on Friday, August 5th. The shares were sold at an average price of $537.00, for a transaction totalling $278,166.00. Following the completion of the sale, the chief accounting officer now directly owns 98 shares of the company's stock, valued at $52,626. Learn More on Ajit Ramalingam's trading history.

Who are Bio-Rad Laboratories' active insiders?

Bio-Rad Laboratories' insider roster includes Michael Crowley (EVP), Ilan Daskal (CFO), Timothy Ernst (EVP), Ronald Hutton (VP), Giovanni Magni (EVP), Ajit Ramalingam (CAO), and Annette Tumolo (EVP). Learn More on Bio-Rad Laboratories' active insiders.

Are insiders buying or selling shares of Bio-Rad Laboratories?

In the last twelve months, insiders at the medical research company sold shares 1 times. They sold a total of 518 shares worth more than $278,166.00. The most recent insider tranaction occured on August, 5th when CAO Ajit Ramalingam sold 518 shares worth more than $278,166.00. Insiders at Bio-Rad Laboratories own 27.4 % of the company. Learn More about insider trades at Bio-Rad Laboratories.

Information on this page was last updated on 8/5/2022.

Ajit Ramalingam Insider Trading History at Bio-Rad Laboratories

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/5/2022Sell518$537.00$278,166.0098View SEC Filing Icon  
See Full Table

Ajit Ramalingam Buying and Selling Activity at Bio-Rad Laboratories

This chart shows Ajit Ramalingam's buying and selling at Bio-Rad Laboratories by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Bio-Rad Laboratories Company Overview

Bio-Rad Laboratories logo
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes. It focuses on selected segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers, and food testing laboratories. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories in the diagnostics market. This segment offers reagents, instruments, and software, which address specific niches within the in vitro diagnostics test market. It sells its products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. In addition, the company offers products and systems to separate complex chemical and biological materials, as well as to identify, analyze, and purify components. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.
Read More

Today's Range

Now: $418.04
Low: $415.09
High: $425.88

50 Day Range

MA: $401.25
Low: $351.71
High: $456.01

2 Week Range

Now: $418.04
Low: $344.63
High: $770.76


248,117 shs

Average Volume

213,032 shs

Market Capitalization

$12.47 billion

P/E Ratio


Dividend Yield